EPIDEMIOLOGY OF PERTUSSIS IN THE YAROSLAVL REGION DURING PLANNED MASS IMMUNIZATION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To identify the regularities of the epidemic process of whooping cough during planned mass immunization for children in the Yaroslavl Region under the current sociodemographic conditions and to elaborate measures to reduce the incidence of this infection. Materials and methods. The authors performed a comparative retrospective epidemiological analysis of the incidence of pertussis, the demographic situation, and the quality of vaccination in the Yaroslavl Region, by using data from the state infectious diseases reports by the Directorate for the Yaroslavl Region, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, and those by the Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, statistical observation forms No. 2 «Information on Infectious and Parasitic Diseases» and No. 6 «Information on Contingents of Children and Adults Vaccinated Against Infectious Disease» over 2004-2016. Results. Whatever the coverage and timeliness of immunization, whooping cough was shown to be characterized by common epidemiological patterns: long-term dynamics, periodic upsurges of morbidity rates, changes in the structure of morbidity, and pronounced territorial irregularity. It was established that the intensity of the epidemic process of pertussis and the features of its manifestations were largely determined by the demographic situation, the size of the pediatric population, social conditions, and the insufficient duration of postvaccination immunity. Thus, in 2016, the incidence of pertussis increased by 8.7% compared to 2015, amounting to 23.1 per 100,000 population, which was 4.1 times the average level in the Russian Federation (5.6 per 100,000 population). The highest morbidity rates were noted among infants under 1 year of age (206.5 per 100,000 babies of this age) and schoolchildren (167.8 per 100,000 children in this category). Conclusion. The features of the present-day epidemiology and clinical course of pertussis necessitate changing the vaccination tactics and introducing revaccination with acellular vaccines in children and adults. In order to protect newborns from whooping cough, it is advisable to promptly vaccinate all family members without a history of this infection, including adults. This will be able to protect a baby in the first 6 months of life before he/she develops postvaccination immunity.

Full Text

Restricted Access

About the authors

Tat’yana A. DRUZHININA

Email: druzhininata@gmail.com
Yaroslavl State Medical University, Ministry of Health of Russia Yaroslavl, Russia

A. A SHOSHIN

Yaroslavl State Medical University, Ministry of Health of Russia Yaroslavl, Russia

E. V CHEPRASOVA

Email: helensur55@yandex.ru
Yaroslavl State Medical University, Ministry of Health of Russia Yaroslavl, Russia

O. V POPOVA

Email: popova_ov@rospotrebnadzor.ru
Directorate for the Yaroslavl Region, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare Yaroslavl, Russia

References

  1. Письмо Роспотребнадзора РФ №01/2412-16-31 от 29.02.2016 «О разъяснении эпидемиологической целесообразности ревакцинации против коклюша»
  2. Резолюция Всероссийской научно-практической конференции с международным участием специалистов по контролю инфекций, связанных с оказанием медицинской помощи «Обеспечение эпидемиологической безопасности и профилактики инфекций в хирургии», 21-23 сентября 2016 г., Казань
  3. Письмо ФГБУ НИИДИ ФМБА России №01-21/1258 от 10.10.2016 «О заболеваемости коклюшем в РФиновых возможностях его вакцинопрофилактики»
  4. Приказ Министерства здравоохранения РФ от 21 марта 2014 г. № 125н «Об утверждении национального календаря профилактических прививок и календаря профилактических прививок по эпидемическим показаниям» (с изменениями и дополнениями)
  5. Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2014 году». М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2015
  6. Брико Н.И., Миндлина А.Я., Полибин Р.В. Универсальность изменений в проявлениях эпидемического процесса антропонозных инфекций за последние десятилетия. Журн. микробиол. 2015; (5): 12-20. Briko N.I., Mindlina A.Ya., Polibin R.V. [Universality of changes in epidemic process manifestations of anthroponosis infections in recent decades]. Zhurnal Microbiologii, Epidemiologii i Immunologii 2015; (5): 12-20. (In Russ.).
  7. Федосеенко В.М., Галицкая М.Г., Ивардава М.И., Гайворонская А.Г., Маянский Н.А., Ботвиньева В.В., Родионова Т.В. Коклюш возвращается? Усовершенствование борьбы с забытой детской инфекцией. Педиатрическая фармакология 2012; (2): 28-36. DOI: http://dx.doi.org/10.15690/pfv9i2.242 Fedoseenko V.M., Galitskaya M.G., Ivanova M.I., Gayvoronskiy A.G., Mayanskiy N.A., Botvin'yeva VV., Rodionova T.V. [Is pertussis coming back? Improving control of a forgotten childhood infection]. Pediatricheskaya Farmacologiya 2012; (2): 28-36. (In Russ.). DOI: http://dx.doi.org/10.15690/ pf.v9i2.242
  8. Инфекционная заболеваемость в Российской Федерации за январь-декабрь 2016 г. http://www.rospotrebnadzor.ru/activities/ statistical-materials/tatictic_ details. php? ELEMENT_ID=7804. Просмотрено 13.03.2017 [Infectious morbidity in the Russian Federation in January-December 2016]. http://www.rospotrebnadzor.ru/activities/statistical-materials/ tatictic_ details. php? ELEMENT_ID=7804.
  9. Лапий Ф.И. Коклюш младенцев: возможные пути предотвращения. Современная педиатрия 2012; (6): 35-8. Lapiy F.I. [Pertussis in infants: potential ways of preventing]. Sovremennaya Pediatriya 2012; (6): 35-8. (In Russ.).
  10. Надрага А.Б., Дыбас И.В. Клинико-эпидемиологические особенности течения коклюша у детей первого года жизни. Здоровье ребенка 2013; (3): 131-5. Nadraga A. B., Dybas I. V. [Clinical and epidemiological features of the course of pertussis in children of the first year of life]. Zdorove rebenka 2013; (3): 131-5. (In Russ.).
  11. Зайцев Е.М., Мазурова И.К., Краснопрошина Л.И., Астахова Т.И., Захарова Н.С. Гуморальный иммунитет к коклюшу и его уровень среди населения. ЖМЭИ 2009; (1): 56-8. Zajcev E.M., Mazurova I.K., Krasnoproshina L.I., Astahova T.I., Zaharova N.S. [Humoral immunity against pertussis and its prevalence in population]. Zhurnal Microbiologii, Epidemiologii i Immunologii 2009; (1): 56-8. (In Russ.).
  12. Бабаченко И.В. Коклюш у детей. СПб: Комментарий, 2014; 157-8. Babachenko I.V. [Pertussis in children]. St.-Peterburg: Kommentariy Publ, 2014; 157-8. (In Russ.).
  13. Final Pertussis Surveillance Report. http://www.cdc.gov/ pertussis/ downloads/pertuss-surv-report-2015.pdf Просмотрено 13.03.2017.
  14. Health Protection Report. Laboratory confirmed cases of pertussis to the enhanced pertussis surveillance programme in England: annual report for 2015. https://www.gov.uk/government/uploads/system/ uploads/attachment_ data/file/521637/hpr1616_prtsss_ann.pdf. Просмотрено 13.03.2017
  15. Таточенко В.К. Коклюш - недоуправляемая инфекция. Вопросы современной педиатрии 2014; (2): 78-82. Tatochenko V.K. [Pertussis - Infection not under Complete Control]. Voprosy Sovremennoi Pediatrii. 2014; 13 (2): 78-8. (In Russ.).
  16. Ward J.I., Cherry J.D., Chang S.J. Bordetella pertussis in vaccinated and unvaccinated adolescents and adults, as assessed in a National Prospective Randomized Acellular Pertussis Vaccine Trial (APERT). Clin. Infect. Dis. 2006; (4): 151-7.
  17. Йозефович О.В., Харит С.М., Каплина С.П.,Гостев В.В., Сидоренко С.В., Калиногородская О.С., Кветная А.С., Тимофеева Е.В., Окунева М.В. Распространенность коклюша у длительно кашляющих детей 6-17 лет, привитых в раннем возрасте АКДС-вакциной. Эпидемиология и вакцинопрофилактика 2012; (5): 56-9. Jozefovich O.V., Harit S.M., Kaplina S.P., Gostev V.V., Sidorenko S.V., Kalinogorodskaya O.S., Kvetnaya A.S., Timofeeva E.V., Okuneva M.V. [The prevalence of pertussis among chronically coughing 6-17 years old children, vaccinated at an early age with DTP vaccine]. Epidemiologiya i Vakcinoprofilaktika 2012; (5): 56-9. (In Russ.).
  18. Skoff T.H., Kenyon C., Cocoros N., Liko J., Miller L., Kudish K., Baumbach J., Zansky S., Faulkner A., Martin S.W. Sources of infant pertussis infection in the United States. Pediatrics 2015; 136(4): 635-41.
  19. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J. 2005; 24(5 Suppl): S58-S61.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies